Taxol (generic name paclitaxel) is a drug that is approved by the Food and Drug Administration for the treatment of ovarian, breast, and lung cancer, as well as Kaposi’s sarcoma. It is used off-label to treat gastroesophageal, endometrial, cervical, prostate, and head and neck cancers. Taxol is obtained from bark of trees such as Taxus brevifolia and Taxus baccata. Please take a look at the following RG links and PDF attachments for more details.
Taxol (generic name paclitaxel) is a drug that is approved by the Food and Drug Administration for the treatment of ovarian, breast, and lung cancer, as well as Kaposi’s sarcoma. It is used off-label to treat gastroesophageal, endometrial, cervical, prostate, and head and neck cancers. Taxol is obtained from bark of trees such as Taxus brevifolia and Taxus baccata. Please take a look at the following RG links and PDF attachments for more details.
Low-dose taxol (paclitaxel) has been found effective in treating non-cancer diseases, such as skin disorders, renal and hepatic fibrosis, inflammation, axon regeneration, limb salvage, and coronary artery restenosis.